Company Overview and News

 
Drone Software Market by Architecture, Offering, Application, Platform, and Region - Global Forecast to 2022

2017-02-21 prnewswire
NEW YORK, Feb. 20, 2017 /PRNewswire/ -- "The rising use of drones in the commercial and military applications is one of the key factors expected to fuel the growth of the drone software market during the forecast period" The drone software market is estimated to be USD 2.85 billion in 2016 and is projected to reach USD 12.33 billion by 2022, at a CAGR of 27.63% from 2016 to 2022. Read the full report: http://www.

 
Aero India Briefs

2017-02-14 thehindubusinessline
Thales and Bharat Dynamics sign MoU to explore Transfer of Technology opportunity for STARStreak missile to India with the support of the UK government. The MoU was signed in the presence of UK Government representatives. Through this MoU, Thales and BDL seek to jointly offer a “Make in India” solution to help service growing international demand for this product. The STARStreak missile is in service in the UK army and has been procured by the defence forces of a number of countries worldwide.

 
Drone Software Market Worth 12.33 Billion USD by 2022

2017-02-13 prnewswire
The report "Drone Software Market by Architecture (Open Source, Closed Source), Offering (App-Based Software, Desktop Software), Application (Control & Data Capture, Image Processing, Analytics), Platform, and Region - Global Forecast to 2022", published by MarketsandMarkets, the market is estimated to be USD 2.85 Billion in 2016 and is projected to reach USD 12.33 Billion by 2022, at a CAGR of 27.

 
CE Week NY to Feature Record Number of Hi-Tech Product Debuts

2016-06-09 prnewswire
NEW YORK, June 9, 2016 /PRNewswire/ -- If it's June in NYC it's CE Week, a two-day exhibit/conference/gathering of the Technorati. This year more than 100 companies are poised to exhibit products and services that span emerging tech categories including smart home, drones, digital health, robotics, wearables, virtual reality, audio and video, and more.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...